Clinical Guidelines
The Missing Piece in the Dark Metabolome Puzzle?
-
By
-
April 8, 2026
-
12 min
By
April 8, 2026
Higher dose weight loss injectable demonstrates nearly five times higher ischaemic optic neuropathy risk than other semaglutide GLP-1 agonists
April 8, 2026
Agency approves multiple dapagliflozin generics to reduce heart failure hospitalization risk and improve glycemic control in adults with type 2 diabetes
April 7, 2026
Researchers examine medication changes in practices with lifestyle medicine access
April 6, 2026